Gene editing regent are essential for the development of cell and gene therapies, but ensuring their quality and consistency is paramount. The decision to manufacture these reagents in-house or source them externally is a strategic one, influenced by factors such as cost, control, scalability, an expertise. By carefully evaluating these factors and considering the specific needs of their organization, businesses can make informed decisions to support their growth in the cell and gene therapy market.
Check out the incredible speaker line-up to see who will be joining Ulrich.
Download The Latest Agenda